Search

everythinglearnresearchcommunity

for

Search:↓

Pegylated interferon-alpha 2a can cause a rare nerve disorder, but early treatment can lead to full recovery.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Upadacitinib effectively treats pyoderma gangrenosum.

The Blood Glucose Management Service improved patient safety and outcomes in managing blood sugar in hospitalized patients.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

The diphosphonate was the most effective at preventing calcification in rats.

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

These medications for BPH have known risks and may have new side effects.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Finasteride may worsen blood sugar control in diabetic patients.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Tirzepatide may improve hair loss by reducing insulin resistance.

SGLT2 inhibitors may help manage PCOS symptoms effectively.

Many drugs can cause lipid metabolism issues, and labels need better warnings.

GLP-1 agonists may help treat certain skin conditions.

GLP-1 agonists may increase the risk of hair loss.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

GLP-1 receptor analogs may help improve metabolism and reproductive health in people with PCOS and obesity.

Liraglutide with metformin reduces body fat and improves blood sugar control better than metformin and inositol in women with prediabetes.

Higher SFRP-4 levels were found in people without a diabetic family history.